Euthymics Bioscience, Inc. — Form D

Euthymics Bioscience, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-27. The offering totals $6.0M, of which $3.0M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Timothy J BarberichDirectorWoburn, MA
Joshua P FunderDirectorMelbourne VIC, C3
Frank P GentileDirectorBoston, MA
Anthony A McKinneyDirectorCambridge, MA
Campbell P MurrayDirectorCambridge, MA
Paul P WeissDirectorMadison, WI
Franklin P BymasterExecutive OfficerBrownsburg, IN
Anthony A McKinneyExecutive OfficerCambridge, MA
Thomas A SheaExecutive OfficerCambridge, MA
Pierre J TranExecutive OfficerCambridge, MA
Paul WeissDirectorMilwaukee, WI
Timothy BarberichDirectorEdina, MN
Campbell MurrayDirectorNOVATO, CA
Campbell A MurrayDirectorMalvern, PA
Anthony McKinneyDirectorCambridge, MA
Anthony McKinneyExecutive OfficerCambridge, MA
Albert L SokolExecutive OfficerBoston, MA
Jeffrey BaileyDirectorWolfeboro, NH
William PappafotopoulosExecutive OfficerCambridge, MA
Brigitte SmithDirectorMelbourne, C3
Daniel OmsteadDirectorBoston, MA
Paul A WeissDirectorMadison, WI
Douglas A BranchExecutive OfficerOKLAHOMA CITY, OK
Andrew P BakerDirectorMelbourne VIC, C3
Frank A GentileDirectorBoston, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2017-06-01D$500K$300K
2012-05-30D/A$28.0M$28.0M
2012-03-16D/A$28.0M$24.3M
2011-03-17D/A$28.4M$22.4M
2010-07-29D$24.2M$5.2M

More